Phage therapy shows 77% success against superbugs; global guidelines released
Scientists are increasingly using bacteriophages, or viruses that target bacteria, to treat antibiotic-resistant infections. A recent study showed a 77% success rate, leading to the release of new international guidelines for clinical use.
Why it matters
Phage therapy offers a critical alternative to traditional antibiotics as the global threat of superbugs continues to rise.
In what seems like an arms race between bacteria and medicine, doctors are turning to something rather unexpected to fight infections that no longer respond to antibiotics: viruses. While viruses are usually associated with making us sick, some of them could actually help save lives by hunting down and killing harmful bacteria.A new approach called phage therapy is gaining attention as scientists look for ways to tackle antibiotic-resistant infections. The results so far are encouraging. In a study involving 100 patients who received personalised treatment in Belgium, 77% showed an improvement in their condition. Now, experts from around the world have come together to issue the first international guidelines for using this treatment, bringing it a step closer to becoming part of clinical practice.Fighting bacteria with virusesAntibiotics have been one of modern medicine's greatest achievements.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in